Oral Squamous Cell Carcinoma Contributes to Differentiation of Monocyte-Derived Tumor-Associated Macrophages via PAI-1 and IL-8 Production.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Aug 2021
Historique:
received: 23 07 2021
revised: 27 08 2021
accepted: 30 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 3 11 2021
Statut: epublish

Résumé

Tumor-associated macrophages (TAMs) promote cancer cell proliferation and metastasis, as well as anti-tumor immune suppression. Recent studies have shown that tumors enhance the recruitment and differentiation of TAMs, but the detailed mechanisms have not been clarified. We thus examined the influence of cancer cells on the differentiation of monocytes to TAM subsets, including CD163

Identifiants

pubmed: 34502382
pii: ijms22179475
doi: 10.3390/ijms22179475
pmc: PMC8430735
pii:
doi:

Substances chimiques

CXCL8 protein, human 0
Interleukin-8 0
Plasminogen Activator Inhibitor 1 0
SERPINE1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 20K23086
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 21K17107
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 21H03141

Références

Curr Med Sci. 2019 Jun;39(3):410-414
pubmed: 31209811
J Invest Dermatol. 2010 Sep;130(9):2179-90
pubmed: 20428185
J Oral Sci. 2016;58(1):59-65
pubmed: 27021541
APMIS. 2015 Mar;123(3):205-14
pubmed: 25639735
Head Neck. 2019 Dec;41(12):4111-4120
pubmed: 31497915
J Oral Maxillofac Surg. 2017 Oct;75(10):2144-2153
pubmed: 28399391
Cancer Sci. 2014 Jan;105(1):1-8
pubmed: 24168081
Sci Rep. 2017 May 11;7(1):1755
pubmed: 28496107
Immunobiology. 2005;210(2-4):153-60
pubmed: 16164022
Oral Oncol. 2009 Apr-May;45(4-5):454-60
pubmed: 18804412
Int J Oral Maxillofac Surg. 2019 Oct;48(10):1279-1288
pubmed: 31053518
Ann Surg Oncol. 2014 Mar;21(3):1031-7
pubmed: 24276640
Appl Immunohistochem Mol Morphol. 2021 May-Jun 01;29(5):359-365
pubmed: 32842026
Int J Mol Sci. 2016 Mar 01;17(3):320
pubmed: 26938527
Curr Opin Lipidol. 1997 Oct;8(5):275-80
pubmed: 9335951
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Sci Rep. 2019 Oct 10;9(1):14611
pubmed: 31601953
Oral Oncol. 2015 Jul;51(7):683-9
pubmed: 25910588
Nat Rev Immunol. 2003 Jan;3(1):23-35
pubmed: 12511873
Eur J Oral Sci. 2014 Jun;122(3):202-9
pubmed: 24796206
EMBO J. 2003 Nov 17;22(22):6127-36
pubmed: 14609958
Oncotarget. 2017 Jan 31;8(5):8633-8647
pubmed: 28052009
J Clin Invest. 2001 Sep;108(5):649-54
pubmed: 11544267
Biochem Biophys Res Commun. 2011 Aug 5;411(3):516-22
pubmed: 21756882
Sci Rep. 2016 Jun 08;6:27548
pubmed: 27271009
Crit Rev Immunol. 2012;32(6):463-88
pubmed: 23428224
Exp Cell Res. 2019 May 15;378(2):131-138
pubmed: 30857971
Cancers (Basel). 2011 Sep 28;3(4):3726-39
pubmed: 24213108
Trends Immunol. 2002 Nov;23(11):549-55
pubmed: 12401408
APMIS. 2018 Sep;126(9):732-738
pubmed: 30160018
Front Oncol. 2018 Jan 23;8:3
pubmed: 29410946
J Exp Clin Cancer Res. 2016 Jan 15;35:12
pubmed: 26769084
J Cytol Mol Biol. 2014 Jan 10;1(1):
pubmed: 24672807
J Oral Pathol Med. 2010 Aug 1;39(7):559-64
pubmed: 20412402
Cancer Metastasis Rev. 2012 Jun;31(1-2):209-19
pubmed: 22101806
J Oral Pathol Med. 2012 Jul;41(6):444-51
pubmed: 22296275
PLoS One. 2014 Dec 02;9(12):e110378
pubmed: 25461761
Braz Dent J. 2013;24(3):194-9
pubmed: 23969905
Int Arch Allergy Immunol. 1992;97(2):178-80
pubmed: 1582709
Nat Rev Cancer. 2004 Jan;4(1):71-8
pubmed: 14708027
Nature. 2013 Apr 25;496(7446):445-55
pubmed: 23619691
Oncol Lett. 2015 Sep;10(3):1390-1396
pubmed: 26622679
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Biomed Res Int. 2014;2014:838632
pubmed: 24883329
Toxicol Sci. 2019 Jun 1;169(2):534-542
pubmed: 30851105
Cancer Sci. 2013 Jul;104(7):945-51
pubmed: 23557330
Biochem Biophys Res Commun. 2018 Mar 4;497(2):583-590
pubmed: 29462614
Immunobiology. 2017 Apr;222(4):651-657
pubmed: 28017495

Auteurs

Kazuki Kai (K)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Masafumi Moriyama (M)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
OBT Research Center, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

A S M Rafiul Haque (ASMR)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Department of Dental Anatomy, Udayan Dental College, House No: 1, Ward No: 7, Chondipur, GPO, Rajpara, Rajshahi 6000, Bangladesh.

Taichi Hattori (T)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Akira Chinju (A)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Chen Hu (C)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Keigo Kubota (K)

Department of Oral-Maxillofacial Surgery, Dentistry and Orthodontics, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.

Yuka Miyahara (Y)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Noriko Kakizoe-Ishiguro (N)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Shintaro Kawano (S)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Seiji Nakamura (S)

Section of Oral and Maxillofacial Oncology, Division of Maxillofacial Diagnostic and Surgical Sciences, Faculty of Dental Science, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH